Price Chart

Profile

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
URL https://www.alkermes.com
Investor Relations URL https://investor.alkermes.com
HQ State/Province N/A
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Growth
Next Earnings Release Feb. 16, 2024 (est.)
Last Earnings Release Oct. 25, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
URL https://www.alkermes.com
Investor Relations URL https://investor.alkermes.com
HQ State/Province N/A
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Growth
Next Earnings Release Feb. 16, 2024 (est.)
Last Earnings Release Oct. 25, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A